Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial

Autor: Muro, Kei, Chung, Hyun Cheol, Shankaran, Veena, Geva, Ravit, Catenacci, Daniel, Gupta, Shilpa, Eder, Joseph Paul, Golan, Talia, Le, Dung T, Burtness, Barbara, McRee, Autumn J, Lin, Chia-Chi, Pathiraja, Kumudu, Lunceford, Jared, Emancipator, Kenneth, Juco, Jonathan, Koshiji, Minori, Bang, Yung-Jue
Zdroj: In The Lancet Oncology June 2016 17(6):717-726
Databáze: ScienceDirect